1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
(
- Contribution to journal › Article
- 2020
-
Mark
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
(
- Contribution to journal › Article
- 2016
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2012
-
Mark
Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study
(
- Contribution to journal › Article
- 2007
-
Mark
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study.
(
- Contribution to journal › Article